David R. Pelizzon, Director at ORTHOPEDIATRICS CORP (KIDS), bought 2,000 shares at $19.50 ($39K) on 2018-05-22, disclosed to the SEC on 2018-05-24.
Open-market purchase of $39k KIDS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| KIDS | SELL | 2026-09-01 | $7.8M | — | Filing → |
| KIDS | SELL | 2026-08-26 | $943K | — | Filing → |
| ATEC | SELL | 2025-12-18 | $4.9M | — | Filing → |